drugset / Trial / NCT02933333

G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor

NCT02933333

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to explore the effect of G-CSF combination with GM-CSF on prevention and treatment of infection in children with malignant tumor.

Timeline

Start
2016-09-27
Primary completion
2020-08-30
Completion
2020-12

Drugs

EvaluationDrugModalityDoseRoute
Subject G-CSF Protein / enzyme biologic 5 ug/kg Subcutaneous
Subject sargramostim Protein / enzyme biologic 5 ug/kg Subcutaneous